The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes
Open accessAbstract
An open-label, first-in-human phase 1/2 study is being conducted to evaluate the safety and efficacy of pancreatic endoderm cells (PECs) implanted in non-immunoprotective macroencapsulation devices for the treatment of type 1 diabetes. We report an analysis on 1 year of data from the first cohort of 15 patients from a single trial site that received subcutaneous implantation of cell products combined with an immunosuppressive regimen. Implants were well tolerated with no teratoma formation or severe graft-related adverse events. After implantation, patients had increased fasting C-peptide levels and increased glucose-responsive C-peptide levels and developed mixed meal-stimulated C-peptide secretion. There were immunosuppression-related transient increases in circulating regulatory T cells, PD1 high T cells, and IL17A+CD4+ T cells. Explanted grafts contained cells with a mature β cell phenotype that were immunoreactive for insulin, islet amyloid polypeptide, and MAFA. These data, and associated findings (Shapiro et al., 2021), are the first reported evidence of meal-regulated insulin secretion by differentiated stem cells in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upon graft removal, a majority of these graft-derived cells immunostained for the general endocrine marker chromogranin A (CHGA).”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the observed circulating C-peptide levels in these studies were too low to induce a measurable clinical benefit attributable to the transplanted cells, these clinical trials have demonstrated that facilitating host-derived vascularization into the graft promoted long-term endocrine cell survival and function in humans.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In other regions of the device, however, host fibroblasts were the predominant cell type, resulting in the deposition of fibrotic tissue rather than host-derived vasculature.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the observed circulating C-peptide levels in these studies were too low to induce a measurable clinical benefit attributable to the transplanted cells, these clinical trials have demonstrated that facilitating host-derived vascularization into the graft promoted long-term endocrine cell survival and function in humans.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As intended, the porous design promoted the growth of host-derived blood vessels inside the device, and this phenomenon was more prominent in regions containing the graft-derived cells.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the ViaCyte clinical trial, the explanted grafts after months in vivo were observed to be highly heterogenous between patients since the cells were transplanted as pancreatic progenitors and allowed to finish differentiating in vivo.33,35”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, while there were regions of C-peptide positive β-like cells, a majority of these endocrine cells stained for the α cell marker glucagon. Ductal cells and rare acinar cells were also observed.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the transplanted PEC-Encap product was well tolerated with few adverse effects, the trial was halted due to insufficient functional product engraftment.33”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these macroencapsulation devices can also promote fibrosis around the implant, further preventing nutrient diffusion.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Importantly, these studies did not detect any serious safety concerns related to the transplanted cells, such as tumor formation.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“An ongoing clinical trial was started in 2017 at seven sites to test this device (clinicaltrials.gov: NCT03163511), and the first round of results have recently been published.33,35”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“While some endocrine cells were observed, fibrosis around the capsule resulted in graft loss, and no insulin secretion from the device was detected.33,34”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“They demonstrated glucose responsive C-peptide production 6-9 months post-transplant as the grafted cells matured from pancreatic progenitors into pancreatic endocrine cells.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., & Rajotte, R. V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430401 · Cited by 5,237
Self-citationThe Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells
D’Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O., Agulnick, A. D., Smart, N. G., Moorman, M. A., KROON, E. J., Carpenter, M. K., & Baetge, E. E. (2006) · Nature Biotechnology · doi:10.1038/nbt1259 · Cited by 1,913
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843
Efficient differentiation of human embryonic stem cells to definitive endoderm
D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., & Baetge, E. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1163 · Cited by 1,730
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3033 · Cited by 1,575
Self-citationRituximab, B-lymphocyte depletion, and preservation of beta-cell function
Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A., Marks, J. B., McGee, P. F., Moran, A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904452 · Cited by 1,093
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 341
Gilglioni, E. H., Bansal, M., St‐Pierre‐Wijckmans, W., Talamantes, S., Kasarinaite, A., Hay, D. C., & Gurzov, E. N. (2025) · Obesity Reviews · doi:10.1111/obr.13899 · Cited by 4
Misra, P. S., & Nostro, M. C. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100321 · Cited by 4
Steenblock, C., Fliedner, S. M. J., Spinas, G. A., Ofir, R., Kugelmeier, P., Ludwig, B., & Bechmann, N. (2023) · doi:10.37349/eemd.2023.00005 · Cited by 4
Lietzke, A. C., Walker, E. M., Bealer, E. J., Crumley, K. M., King, J., Stendahl, A. M., Zhu, J., Pearson, G. L., Levi-D’Ancona, E., Henry-Kanarek, B. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.26.605318 · Cited by 4
Cavalli, E., Nicoletti, G. R. P., & Nicoletti, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165621 · Cited by 3
Singh, H., Bhaskar, R., Ghosh, S., Mishra, P. K., Singh, D. K. K., Sinha, J. K., & Han, S. S. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103293 · Cited by 4
Overview of the major clinical trials investigating stem cells–based therapies for diabetes
Lin, T.-M., Lin, C.-H., Lin, C.-S., & Lin, C.-S. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101738 · Cited by 4
Wang, Z., Zhou, H., Liao, R., Chen, X., Zhang, Q., Liu, J. Z., Zhang, W., & Shen, Y. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115886 · Cited by 5
Peralta, F. G., Pinés-Corrales, P. J., Santos, E., Cuesta, M., Albarrán, O. G., Azriel, S., Castaño, L. A., Mathieu, C., & on behalf of the AGORA Diabetes Collaborative Group (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020418 · Cited by 4
Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitations
Du, C., Liu, Y., Lu, X., Zhang, M., Jiang, S., Cao, Z., Yang, G., Qiu, J., Zhang, T., & Zhao, Y. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217968 · Cited by 3
Mazloum, A., Feoktistova, S. G., Gubaeva, A., Alsalloum, A., Mityaeva, O. N., Kim, A., Бодунова, Н. А., Woroncow, M. V., & Volchkov, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168110 · Cited by 4
The controversy about the effects of artemisinins on pancreatic α cell reprogramming and diabetes
Zhang, Y., Lin, X., & Li, J. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.12.005 · Cited by 3
Tol, M. C., de Bont, D. F. A., Boon, W., de Koning, E. J. P., & van Apeldoorn, A. A. (2023) · Transplant International · doi:10.3389/ti.2023.11077 · Cited by 3
Jang, S., Shin, S., Jeong, Y., & Lim, D. (2023) · Organoid · doi:10.51335/organoid.2023.3.e16 · Cited by 3
Hydrogel-Composited Laminate for Islet Immune-Isolation to Treat Type 1 Diabetes
Wang, Y., Wang, K., Wang, X., Luo, Y., & Chen, H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12359 · Cited by 3
Latest advancements in the development of new therapies for type 1 diabetes
Alzhanuly, B., & Sharipov, K. O. (2024) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2024_75 · Cited by 3
Stem cell-derived β cells go in monkeys
Grapin‐Botton, A., & Ludwig, B. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.03.010 · Cited by 3
Dadheech, N., de León, M. B., Cuesta‐Gomez, N., Jasra, I. T., Pawlick, R. L., Marfil‐Garza, B. A., Verhoeff, K. K., Sapkota, S., Razavy, H., Anwar, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.09.552676 · Cited by 3
Diminished Immune Cell Adhesion in Hypoimmune ICAM-1 Knockout Pluripotent Stem CellsPreprint
Saha, S., Haynes, W. J., Rio, N. M. D., Young, E. E., Zhang, J., Seo, J., Huang, L., Holm, A. M., Blashka, W., Murphy, L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.07.597791 · Cited by 3
Transplantation of Islet Organoids into Brown Adipose Tissue in a Diabetic Mouse Model
Sun, A., Singh, M., Bamrah, M., Li, W., Aguirre, A., & Wang, P. (2024) · Methods in molecular biology · doi:10.1007/7651_2024_588 · Cited by 2
Lee, J. E., Lee, C. W., Han, A., Kim, J., & Lee, D. R. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04532-x · Cited by 2
Navigating challenges in human pluripotent stem cell-derived islet therapy for type 1 diabetes
Usama, M., Deng, Y., Chen, Y., Milland, T., Malleshaiah, M. K., & Aghazadeh, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625439 · Cited by 4
Implant Renal Injury‐Responsive Cells to Supplement Erythropoietin and Protect Kidney Injury
Nie, H., Liang, C., He, Y., Wang, S., Zhang, X., Duan, J., Huang, J.-L., Yu, C., Wang, Y., Zhao, Z., et al. (2025) · MedComm · doi:10.1002/mco2.70438 · Cited by 2
Kawai, K., Doğan, F., Alagpulinsa, D. A., Pop, R., Veres, A., Sobell, D., Deng, H., Collins, S. H., Zhang, J., Chapin, M. H., et al. (2025) · Xenotransplantation · doi:10.1111/xen.70098 · Cited by 2
Waris, S., Begam, H. H., Kumar, M. P., Abdulrasool, Z., Avudaiappan, M., Butler, A. E., & Nandakumar, M. (2026) · Cells · doi:10.3390/cells15020191 · Cited by 6
Type 1 Diabetes and Islet Encapsulation: From Historical Milestones to Cutting-Edge Advances
Mukherjee, S., Mandal, S., Oberholzer, J., & Omid Veiseh, A. (2026) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110824-024435 · Cited by 2
Lin, T.-M., Chang, H., Lin, T.-C., Lin, C.-S., Sun, Y., & Lin, C. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70800 · Cited by 2
Metabolic reprogramming drives pancreatic β cell neogenesis from α cells
Zhang, Y., Lu, G., Xie, W., Xu, P. H., Liu, C., Babošová, O., Reilly, J. C., Li, Z., Chen, L., Zhou, L., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02293-z · Cited by 2
The role of noncoding RNAs in pancreatic birth defects
Yang, Z., & Parchem, R. J. (2023) · Birth Defects Research · doi:10.1002/bdr2.2178 · Cited by 2
A critical view of the revolution of precision medicine: genetics, epigenetics, sex, and gender
Glezerman, M., Ciechanover, A. J., & Legato, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823937-7.00004-3 · Cited by 2
Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk
Hillenius, S., Montilla‐Rojo, J., Eleveld, T. F., Salvatori, D. C. F., & Looijenga, L. H. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_18 · Cited by 2
Diabetes treatment by conversion of gut epithelial cells to insulin‐producing cells
Accili, D., Talchai, S. C., Bouchi, R., Lee, A. Y., Du, W. J., Kitamoto, T., McKimpson, W. M., Belvedere, S., & Lin, H. V. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14175 · Cited by 2
Pancreatic Diseases: Genetics and Modeling Using Human Pluripotent Stem Cells
Lee, Y., & Lee, K. (2024) · International Journal of Stem Cells · doi:10.15283/ijsc24036 · Cited by 2
β-Cell Regeneration Is Driven by Pancreatic Plasticity
Holguín-Horcajo, A., Sancho, R., & Rovira, M. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-62232-8_4 · Cited by 4
Tran, H. T., Rodprasert, W., Padeta, I., Oontawee, S., Purbantoro, S. D., Thongsit, A., Siriarchavatana, P., Srisuwatanasagul, S., Egusa, H., Osathanon, T., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318204 · Cited by 2
Advancing diabetes treatment: from human beta cell technology to bioartificial pancreas development
Sá, J., Sá, S. C., Leménager, H., Costa, R., Onteniente, B., Soares, R. A., Ribeiro, V. P., & de Oliveira, A. L. F. (2025) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2025.1524518 · Cited by 5
Cell Therapy for Type 1 Diabetes Mellitus: a Review of Clinical Trials
Danilevskiĭ, M. I., Захарова, О. В., Skaletskiy, N. N., Basok, Y. B., Roumiantsev, S. A., & Lyundup, A. V. (2025) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-025-06444-5 · Cited by 4
Stammzellbasierte Inselzelltransplantation: Meilenstein zur Therapie des Typ-1-Diabetes
Ludwig, B. (2023) · Deutsches Ärzteblatt · doi:10.3238/persdia.2023.11.03.03 · Cited by 2
Developments in endoderm and pancreatic β-cell differentiation from human pluripotent stem cells
Lee, D. H., Choo, H., Choi, H. Y., & Lee, S. H. (2024) · Organoid · doi:10.51335/organoid.2024.4.e5 · Cited by 2
Du, W. J., Wang, J., Kuo, T., Wang, L., McKimpson, W. M., Son, J., Watanabe, H., Kitamoto, T., Lee, Y., Ratner, L. E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.21.484748 · Cited by 2
Restoring glucose homeostasis with stomach-derived human insulin-secreting organoidsPreprint
Huang, X., Gu, W., Zhang, J., Lan, Y., Colarusso, J. L., Li, S., Pertl, C., Lu, J., Kim, H., Zhu, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.15.520488 · Cited by 2
Generation of gastric insulin-secreting organoids from human stomach samplePreprint
Huang, X., & Zhou, Q. (2023) · Research Square · doi:10.21203/rs.3.pex-2147/v1 · Cited by 2
Endocrine-enriched stem cell-derived islets improve long-term safety in vivoPreprint
Setyono, E. S. A., Rogers, N. K., Scheibner, K., Schirge, S., Reich, H., Sterr, M., Öztürk, T., Franzenburg, S., Lithovius, V., & Lickert, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.22.671768 · Cited by 2
Teles, L. N., LI, C., Wilkes, Z. M., Stock, A. A., & Tomei, A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_15 · Cited by 1
Islet transplantation in Korea
Lee, J., & Yoon, K.-H. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14264 · Cited by 3
Cobo-Vuilleumier, N., Lorenzo, P., Vázquez, E. M., Noriega, L., Nano, R., Piemonti, L., Martín, F., & Gauthier, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470881 · Cited by 1
Controlling spheroid attachment improves pancreatic beta cell differentiation from human iPS cells
Horikawa, A., & Michiue, T. (2024) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-024-00991-3 · Cited by 1
Zushi, N., Takuma, M., Endo, A., Suzuki, M., Wu, Y., Shiraki, N., Kume, S., & Fujie, T. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01446 · Cited by 1
Na+/K+-ATPase: a multifunctional target in type 2 diabetes and pancreatic islets
Mou, L., Fu, Z., Wang, T. B., Chen, Y., Luo, Z., Wang, X., & Pu, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1555310 · Cited by 1
Pharmacotherapy of type 1 diabetes – part 3: tomorrow
Rendell, M. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2468906 · Cited by 1
Qu, B., Xie, T., Xie, Y., Guang, Z., Han, Y., Li, M., & Tong, X. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02621-0 · Cited by 1
Siracusano, G., Deambrogio, F., Sordi, V., Malnati, M., Piemonti, L., & Chimienti, R. (2025) · Transplant International · doi:10.3389/ti.2025.15433 · Cited by 1
Emerging applications of bioactive peptides and proteins in the treatment of periodontitis
Sun, J., Li, Q., Yu, L., Ma, Y., Deng, P., Chen, Q., & Sun, P. (2026) · Nano Research · doi:10.26599/nr.2026.94908547 · Cited by 1
Kuncha, J., Veeraswamy, S. D., Darden, C. M., Kirkland, J., Lawrence, M. C., Danobeitia, J. S., & Naziruddin, B. (2026) · Cells · doi:10.3390/cells15060532 · Cited by 2
Li, Z., Kang, Y., & Niu, Y. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70211 · Cited by 1
Hakimi, H., Yousefi, M. H., Mohammadi, Z., Komeili-Movahed, S., Afkhami, H., & Abdolmohammadi, M.-H. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00647-6 · Cited by 1
Biomaterials for clinical therapy utilizing cells differentiated from human pluripotent stem cells
Higuchi, A., Wang, T., Kang, X., Tian, Z., Sung, T., & Umezawa, A. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100860 · Cited by 1
Stem cell therapies for treatment of diabetes mellitus
Guo, F., Song, Y., & Qin, G. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004150 · Cited by 1
Kondo, T., Suga, H., Watari, K., Taga, S., Sakakibara, M., Soen, M., Kawamoto, I., Nishida, K., Emoto, R., Shiraki, Y., et al. (2026) · Stem cell research & therapeutics · doi:10.1186/s13287-026-05098-y · Cited by 1
Habeeb, M. A., Vishwakarma, S. K., Habeeb, S., & Khan, A. A. (2022) · World Journal of Translational Medicine · doi:10.5528/wjtm.v10.i1.1 · Cited by 1
Reprogramming of pancreatic islet cells for regeneration and rejuvenation
Hirano, M., & Yamada, Y. (2023) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2023.102099 · Cited by 1
Stem Cell Therapy For Type 1 Diabetes
Schweitzer, J. I., & Gallicchio, V. S. (2023) · Journal Of Stem Cell Research · doi:10.52793/jscr.2023.4(2)-49 · Cited by 1
Saber, N., & Kieffer, T. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_4 · Cited by 1
Self-citationIslet Macroencapsulation: Strategies to Boost Islet Graft Oxygenation
Ludwig, B., Heller, C., Sarangova, V., & Welzel, P. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_12 · Cited by 1
Scaffolds for Encapsulation of Stem Cell-Derived β Cells
de Vries, R. H. W., & van Apeldoorn, A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_7 · Cited by 2
Greasing the machinery toward maturation of stem cell-derived β cells
Karampelias, C., & Lickert, H. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.05.001 · Cited by 1
Verhoeff, K. K., & Shapiro, A. M. J. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_18 · Cited by 1
Wen, Y., Li, J., Mukama, O., Huang, R., Deng, S., & Li, Z. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.03.007 · Cited by 1
Turner syndrome: the promise of fertility via stem cell technology
Szeliga, A., Malcher, A., Niwczyk, O., Olszewska, M., Kurpisz, M. K., Męczekalski, B., & Adashi, E. Y. (2025) · HORMONES · doi:10.1007/s42000-025-00647-1 · Cited by 1
Cheah, Y. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.364 · Cited by 1
Introduction: Trends, Puzzles, and Hopes for the Future of Healthcare
Ehsani, S., Glauner, P., Plugmann, P., & Thieringer, F. M. (2022) · Future of business and finance · doi:10.1007/978-3-030-99838-7_1 · Cited by 1
Transplantation of Pancreatic Islets
Rao, J. S., Bellin, M. D., & Hering, B. J. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch166 · Cited by 1
Jarc, L., Bandral, M., Zanfrini, E., Lesche, M., Kufrin, V., Sendra, R., Pezzolla, D., Giannios, I., Khattak, S., Neumann, K., et al. (2023) · eLife · doi:10.7554/elife.89962.2 · Cited by 1
Yoshihara, E. (2024) · Annals of Translational Medicine · doi:10.21037/atm-24-129 · Cited by 1
小児の薬物療法に薬剤師がどのように関与できるか (特集 ライフステージに合った薬物療法の提供 : 新生児,小児,妊婦・授乳婦,高齢者の薬物療法に薬剤師がどのように関与できるか)
石川, 洋. (2012) · Clinical pharmacist : 新時代の薬剤師ジャーナル
Industry Updates from the Field Of Stem Cell Research and Regenerative Medicine in December 2021
Ilić, D., & Liović, M. (2022) · Regenerative Medicine · doi:10.2217/rme-2022-0011
Stammzelltherapie bei Typ-1-Diabetes
Ludwig, B. (2022) · Diabetes aktuell · doi:10.1055/a-1834-3188
Yu, T., XinYi, C. H. E. N., Cissy Qing, Y. U., & Arial Yi, Z. E. N. G. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0031
Verso una nuova fonte di β-cellule per la cura del diabete mellito di tipo 1
Zamarian, V., Pellegrini, S., & Sordi, V. (2022) · il Diabete · doi:10.30682/ildia2202h
Ajima, K., Tsuda, N., Takaki, T., Furusako, S., Matsumoto, S., Shinohara, K., Yamashita, Y., Amano, S., Oyama, C., & Shimoda, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4095380
De la biologie du développement à la thérapie cellulaire du diabète
Schreiber, V., & Gradwohl, G. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.05.009
Pluripotent stem cells as a therapy for type 1 diabetes
Tuch, B. E., Cheng, I. S., Dang, H. P., Chen, H., & Dargaville, T. R. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.03.001
Jarc, L., Bandral, M., Zanfrini, E., Lesche, M., Kufrin, V., Sendra, R., Pezzolla, D., Giannios, I., Khattak, S., Neumann, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.06.556505
Cobo‐Vuilleumier, N., Rodríguez-Fernández, S., López–Noriega, L., Lorenzo, P. I., Franco, J., Lachaud, C. C., Vázquez, E. M., Legido, R. A., Dorronsoro, A., López‐Fernández‐Sobrino, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.18.558230
Jarc, L., Bandral, M., Zanfrini, E., Lesche, M., Kufrin, V., Sendra, R., Pezzolla, D., Giannios, I., Khattak, S., Neumann, K., et al. (2023) · eLife · doi:10.7554/elife.89962.1
Verhoeff, K. K., & Shapiro, A. M. J. (2023) · Springer eBooks · doi:10.1007/978-981-99-0846-2_18-1
Polymers for implantable bioartificial pancreas
Chen, J. T., Lee, J. M., Lim, E. X. H., Koh, Y., Yeong, W. Y., & Teo, A. K. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99690-7.00012-1
Selecting Biocompatible Biomaterials for Stem Cell-Derived β-Cell Transplantation
de Vries, R. H. W., & van Apeldoorn, A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_6
Minimal SC-β-Cell Properties for Transplantation in Diabetic Patients
Cochrane, V. A., Xiao, Y., Maachi, H., & Hebrok, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_22
3D Organoids of Mesenchymal Stromal and Pancreatic Islet Cells
Westenfelder, C. S., & Gooch, A. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_9
Considerations Pertaining to Implant Sites for Cell-Based Insulin Replacement Therapies
Marfil‐Garza, B. A., Cuesta‐Gomez, N., & Shapiro, A. M. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_16 · Cited by 1
Uitbeijerse, B. S., Nijhoff, M. F., & de Koning, E. J. P. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00030.2024
Abdelfatah, F. A., El-Hamid, A. A., Emara, A. S., & Rezk, E. F. (2024) · Benha Medical Journal · doi:10.21608/bmfj.2024.216972.1838
An Autoclavable and Transparent Thermal Cutter for Reliably Sealing Wet Nanofibrous Membranes
Fang, C., Gu, Y., Shi, H., Hu, J. F., Wang, Y., Pan, M., Feng, J., Li, Y., Ma, Y., Wang, T., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c02096
Cell-based strategies for the treatment of injury to the developing lung
Pierro, M., & Thébaud, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91824-4.00020-4
Peng, X., Li, L., Peng, Y., Zhou, G., & An, Z. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2322047
Teo, A. K. S., Tan, K. S. M., Koh, Y. X., Koh, A., & Teo, A. K. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00143-5
Stem Cell-Derived Islet Cells: A Novel Approach to Treating Type 1 Diabetes
Vijayalaxmi, R. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-24606
Jimenez, A., Naughton, M., Zhang, K., Resnick, G. F., & Watson, L. J. (2025) · Georgetown Medical Review · doi:10.52504/001c.138500
Development of an Immunoisolated Endovascular Islet Cell Stent to Treat Type I Diabetes MellitusPreprint
Gaston, B., Singh, V., Kharga, A., Deng, K., Lee, K. M., Lei, J., Markmann, J. F., & Succi, M. D. (2025) · Research Square · doi:10.21203/rs.3.rs-6441612/v1
Metadata
- Authors
- Ramzy, A., Thompson, D. M., Ward-Hartstonge, K. A., Ivison, S., Cook, L., Garcia, R. V., Loyal, J., Kim, P. T. W., Warnock, G. L., Levings, M. K., & Kieffer, T. J.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Kieffer, Timothy J.
- ORCID
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 28
- Issue
- 12
- Pages
- 2047-2061.e5
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W3214753991
- Cited by
- 342
- References
- 55
- Citations by year
- 2026: 46 · 2025: 75 · 2024: 75 · 2023: 66 · 2022: 76 · 2021: 3
- FWCI
- 51.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell stem cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Stem Cell Network
- California Institute for Regenerative Medicine
- Juvenile Diabetes Research Foundation United States of America
- BC Children’s Hospital
- Juvenile Diabetes Research Foundation Canada
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- type 1 diabetes, pluripotent stem cells, cell therapy, macroencapsulation, C-peptide secretion, glucose-dependent insulin secretion, beta cell differentiation, regulatory T cells, immunosuppression, graft safety, amylin, MafA
- MeSH terms
- C-Peptide, Cell Differentiation, Diabetes Mellitus, Type 1, Endoderm, Glucose, Humans, Insulin, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
